RPS26P38

Across TCGA pan-cancer cohorts, RPS26P38 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RPS26P38’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where RPS26P38 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPS26P38 is over-expressed in tumor.

LUSC, READ, and LUAD are the cancer types where RPS26P38 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS26P38 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	Male	All	+0.132	.008	3	view →
READ	All	III,IV	+0.455	<.001	2	view →
LUAD	All	All	+0.199	.015	2	view →
LIHC	All	All	+0.062	.028	2	view →
KIRC	All	All	+0.063	.012	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

RPS26P38–LUSC

Open the LUSC breakdown →